Cytomx Therapeutics, Inc. (CTMX)

Last Year

28-Apr-23 -- 27-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

19

0

6

+1

0

+2

0

+3

Two Year Chart

28-Apr-22 -- 27-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
21-Mar-24 4:41 PM View:	19-Mar-24 Sale ($10.99K)	Rowland Lloyd A General Counsel		Cytomx Therapeutics, Inc. - CTMX	66% 71.09K to 117.73K	0	0	--	--	Show Txns Hide Txns

21-Mar-24 4:38 PM View:	19-Mar-24 Sale ($6.20K)	Ogden Christopher SVP, Finance and Accounting		Cytomx Therapeutics, Inc. - CTMX	96% 43.77K to 85.69K	0	0	--	--	Show Txns Hide Txns

28-Mar-24 7:12 PM View:	26-Mar-24 Option Exercise $172.87K	McCarthy Sean A. CEO Director		Cytomx Therapeutics, Inc. - CTMX	51% 481.98K to 727.41K	0	0	--	--	Show Txns Hide Txns

21-Mar-24 4:37 PM View:	19-Mar-24 Sale ($26.68K)	Belvin Marcia SVP, Chief Scientific Officer		Cytomx Therapeutics, Inc. - CTMX	20% 140.82K to 168.58K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 8:37 PM View:	18-Jan-24 Grant 0	Chu Yu-Waye Chief Medical Officer		Cytomx Therapeutics, Inc. - CTMX	100% 0 to 26.25K	0	0	--	--	Show Txns Hide Txns

21-Mar-24 4:36 PM View:	19-Mar-24 Sale ($13.69K)	Landau Jeffrey B Chief Business Officer		Cytomx Therapeutics, Inc. - CTMX	53% 76.93K to 117.74K	0	0	--	--	Show Txns Hide Txns